Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Cava Group (CAVA) reported fourth-quarter sales growth and gave a rosy outlook for 2026, outperforming its fast-casual rivals and bucking expectations for a slowdown. Sales from established restaurants are seen expanding 3% to 5% this year, with the company citing price increases and customers opting for more expensive options as helping to offset a decline in store visits. Cava shares jumped 9.2% after the close of regular trading in New York, with the stock having advanced nearly 16% so far this year.

- PayPal (PYPL) closed up 6.7% to $47.01 in New York Tuesday, giving it a market value of $43.3 billion after Bloomberg reported that Stripe is considering an acquisition of all or parts of PayPal Holdings Inc., according to people familiar with the matter. The deliberations are early and there's no certainty they'll lead to a transaction, the people said.

- Novo Nordisk (NOV) next-generation weight-loss drug CagriSema had disappointing trial results, sparking calls for a radical shift in the company's strategy. Some investors are urging Novo to diversify away from diabetes and obesity, citing the risk of relying on these two areas, and suggesting fields such as rare diseases, heart disease, or cancer treatment.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Kristine Aquino, Carol Massar and Tim Stenovec

- Advanced Micro Devices (AMD) shares rise after news that Meta Platforms will deploy data center gear based on processors from AMD in a deal worth “double-digit billions” of dollars per gigawatt.

- Texas Instruments (TXN) shares slid nearly 5% after the chipmaker indicated that spending on new plants and equipment will remain higher than some investors had anticipated. During a presentation Tuesday, the company said that the expenditures will be $2 billion to $3 billion this year, reiterating a previous stance. The target for 2027 and beyond “depends on revenue and expected growth,” it said.

- Keysight Technologies (KEYS) shares jump 17% in premarket trading after the measurement instruments company guided for above-20% growth for revenue and earnings in FY26, beating estimates. Booming AI workloads, along with faster growth in other business areas including wireless and defense, are all boosting growth, according to analysts.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Home Depot (HD) shares rise after the company reported a key sales metric that beat expectations in the latest quarter on steady demand, though the retailer cautioned that macroeconomic challenges remain.
-Advanced Micro Devices (AMD) shares gain after news Meta Platforms will deploy data center gear based on processors from AMD in a deal worth “double-digit billions” of dollars per gigawatt.
- Novo Nordisk (NOVOB) next-generation weight-loss drug CagriSema had disappointing trial results, sparking calls for a radical shift in the company's strategy. Some investors are urging Novo to diversify away from diabetes and obesity, citing the risk of relying on these two areas, and suggesting fields such as rare diseases, heart disease, or cancer treatment.

See omnystudio.com/listener for privacy information.